ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Psychiatry

Top Psychiatry Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHANDRALEKHA BOMMAKANTI M.D.

Psychiatry

6,490

$827K

300
44 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 25%

$127
Average prescription price

Avg: $135

SHEILA THAKOR MD

Psychiatry

6,440

$1.1M

208
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 25%

$170
Average prescription price

Avg: $135

GEORGE PLANAVSKY MD

Psychiatry

6,055

$1.07M

270
38 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 25%

$176
Average prescription price

Avg: $135

LAUREN GREENE M.D.

Psychiatry

5,981

$995K

146
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$166
Average prescription price

Avg: $135

DAVID SCHLAGEL M.D.

Psychiatry

5,926

$498K

385
107 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $135

JAMES LEAN MD

Psychiatry

5,866

$963K

215
41 are 65+

24%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 25%

$164
Average prescription price

Avg: $135

KIMBERLY NESTLER MD, PHD

Psychiatry

5,810

$818K

114
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 25%

$141
Average prescription price

Avg: $135

PATRICK HELFENBEIN M.D.

Psychiatry

5,771

$837K

475
82 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 25%

$145
Average prescription price

Avg: $135

JOSEFINA RODRIGUEZ MD

Psychiatry

5,635

$925K

325
63 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 25%

$164
Average prescription price

Avg: $135

JOHN BATTAGLIA MD

Psychiatry

5,611

$648K

91
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 25%

$116
Average prescription price

Avg: $135

DAVID METZLER MD

Psychiatry

5,572

$776K

295
98 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$139
Average prescription price

Avg: $135

ROBERT CALLAGHAN M.D.

Psychiatry

5,526

$709K

279
24 are 65+

47%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $135

STEVEN ANDREWS MD

Psychiatry

5,462

$1.06M

230
53 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 25%

$194
Average prescription price

Avg: $135

SARAH SCHAETTLE MD

Psychiatry

5,419

$695K

148
37 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $135

BRIAN PROCTOR MD

Psychiatry

5,323

$685K

302
59 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 25%

$129
Average prescription price

Avg: $135

ROYLE EENIGENBURG MD

Psychiatry

5,238

$981K

252
34 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 25%

$187
Average prescription price

Avg: $135

GUY POWERS MD

Psychiatry

5,161

$683K

196
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 25%

$132
Average prescription price

Avg: $135

JAGADEESWARA MUSUNURU M.D.

Psychiatry

4,986

$826K

314
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

21%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 25%

$166
Average prescription price

Avg: $135

DONALD JACOBSON MD

Psychiatry

4,934

$656K

227
66 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$133
Average prescription price

Avg: $135

YONG LI

Psychiatry

4,882

$505K

288
71 are 65+

26%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$103
Average prescription price

Avg: $135

KATIE FASSBINDER M.D.

Psychiatry

4,790

$1.26M

128
17 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

41%
prescriptions for brand name drugs

Avg: 25%

$263
Average prescription price

Avg: $135

C VAUGHN MD

Psychiatry

4,739

$545K

338
168 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$115
Average prescription price

Avg: $135

RINA PATEL MD

Psychiatry

4,566

$370K

270
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 25%

$81
Average prescription price

Avg: $135

GILDA WINTER MD

Psychiatry

4,544

$569K

263
46 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 25%

$125
Average prescription price

Avg: $135

JOHN CHARLES MD

Psychiatry

4,538

$641K

283
102 are 65+

24%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 25%

$141
Average prescription price

Avg: $135

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank